{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:58:25Z","timestamp":1793703505718,"version":"4.5.1"},"reference-count":42,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Excessive bleeding is relatively common in adult inpatients, whether as the primary reason for admission or as a development during the hospital stay. Common causes include structural issues, medication effects, and systemic illnesses; occasionally, unexpected bleeding can develop as a result of an undiagnosed or newly acquired bleeding disorder. The first step in caring for the inpatient who is bleeding is to determine whether the bleeding symptom is truly new or whether the patient has a history of abnormal bleeding. Patients with a history of abnormal bleeding may warrant evaluation for inherited bleeding disorders, such as platelet function disorders, von Willebrand disease, hemophilia, or rare factor deficiencies. Patients with no history of bleeding, for whom other causes, such as liver dysfunction, medication effect, disseminated intravascular coagulation, or certain vitamin deficiencies have been ruled out may require evaluation for acquired coagulopathies, such as acquired hemophilia or acquired von Willebrand disease. Here, we present 3 cases to discuss the diagnosis and management of the 2 most common acquired bleeding disorders as well as a patient with a congenital bleeding disorder with a historical diagnosis.<\/jats:p>","DOI":"10.1182\/blood.2021014766","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T20:53:52Z","timestamp":1674075232000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["How I approach bleeding in hospitalized patients"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-8990","authenticated-orcid":false,"given":"Bethany Samuelson","family":"Bannow","sequence":"first","affiliation":[{"name":"1Division of Hematology\/Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-8797","authenticated-orcid":false,"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, Washington Center for Bleeding Disorders, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2023083115242905000_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1351-8216.2003.00832.x","article-title":"Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States","volume":"10","author":"Kirtava","year":"2004","journal-title":"Haemophilia"},{"issue":"1","key":"2023083115242905000_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.maturitas.2012.02.008","article-title":"Inherited bleeding disorders in older women","volume":"72","author":"Kadir","year":"2012","journal-title":"Maturitas"},{"issue":"1","key":"2023083115242905000_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"196: Thromboembolism in pregnancy","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2023083115242905000_bib4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"Hsieh","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"2023083115242905000_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.hoc.2021.07.009","article-title":"Factor XIII deficiency: a review of clinical presentation and management","volume":"35","author":"Pelcovits","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2023083115242905000_bib6","first-page":"1","article-title":"Inherited platelet function disorders (IPFDs)","volume":"63","author":"Dorgalaleh","year":"2017","journal-title":"Clin Lab"},{"issue":"21","key":"2023083115242905000_bib7","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020010116","article-title":"How I treat dysfibrinogenemia","volume":"138","author":"Casini","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2023083115242905000_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"2023083115242905000_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"2023083115242905000_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0111","article-title":"The coagulopathy of liver disease: a shift in thinking","volume":"82","author":"Ballantine","year":"2021","journal-title":"Br J Hosp Med (Lond)"},{"issue":"7","key":"2023083115242905000_bib11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jth.15743","article-title":"Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study","volume":"20","author":"Afzal","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2023083115242905000_bib12","doi-asserted-by":"crossref","first-page":"e12724","DOI":"10.1002\/rth2.12724","article-title":"Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: a systematic review","volume":"6","author":"Evans","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"2023083115242905000_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/1076029616668406","article-title":"Four-factor prothrombin complex concentrate for coagulopathy reversal in patients with liver disease","volume":"23","author":"Huang","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"48","key":"2023083115242905000_bib14","first-page":"1645","article-title":"Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts","volume":"49","author":"Koruk","year":"2002","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"2023083115242905000_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"2023083115242905000_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023083115242905000_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"2023083115242905000_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"2023083115242905000_bib19","first-page":"165","article-title":"A\u00a0reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time","volume":"12","author":"Gerrard","year":"1989","journal-title":"Clin Invest Med"},{"issue":"8","key":"2023083115242905000_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1537-2995.2001.41080977.x","article-title":"Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss","volume":"41","author":"Valeri","year":"2001","journal-title":"Transfusion"},{"issue":"4","key":"2023083115242905000_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"issue":"10241","key":"2023083115242905000_bib22","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"HALT-IT Trial Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"2023083115242905000_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1213\/00000539-198509000-00008","article-title":"Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation","volume":"64","author":"Kang","year":"1985","journal-title":"Anesth Analg"},{"issue":"6","key":"2023083115242905000_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MBC.0b013e3282f9adf9","article-title":"A\u00a0comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood","volume":"19","author":"Thalheimer","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"2023083115242905000_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MBC.0b013e32832ca388","article-title":"The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis","volume":"20","author":"Bitting","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"2023083115242905000_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges","volume":"40","author":"Tiede","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2023083115242905000_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/hae.12627","article-title":"Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A","volume":"21","author":"Kruse-Jarres","year":"2015","journal-title":"Haemophilia"},{"issue":"4","key":"2023083115242905000_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2516.2012.02748.x","article-title":"Combined treatment with APCC (FEIBA\u00ae) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience","volume":"18","author":"Holmstrom","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"2023083115242905000_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/hae.14450","article-title":"Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: a scoping review of the literature","volume":"28","author":"Thomas","year":"2022","journal-title":"Haemophilia"},{"issue":"6","key":"2023083115242905000_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jth.14784","article-title":"Laboratory testing in hemophilia: impact of factor and non-factor replacement therapy on coagulation assays","volume":"18","author":"Peyvandi","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2023083115242905000_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia A","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2023083115242905000_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2023083115242905000_bib33","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2023083115242905000_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br J Haematol"},{"issue":"19","key":"2023083115242905000_bib35","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","volume":"136","author":"Leebeek","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2023083115242905000_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"2023083115242905000_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"9","key":"2023083115242905000_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jogc.2022.03.017","article-title":"Postpartum hemorrhage in women with von Willebrand disease: consider other etiologies","volume":"44","author":"Kazi","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"5","key":"2023083115242905000_bib39","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1213\/ANE.0000000000004424","article-title":"Trends in postpartum hemorrhage in the United States from 2010 to 2014","volume":"130","author":"Reale","year":"2020","journal-title":"Anesth Analg"},{"issue":"10084","key":"2023083115242905000_bib40","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"2023083115242905000_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-0412.2012.01361.x","article-title":"Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review","volume":"91","author":"Naoulou","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2023083115242905000_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tmrv.2018.06.003","article-title":"Inherited bleeding disorders in the obstetric patient","volume":"32","author":"Bannow","year":"2018","journal-title":"Transfus Med Rev"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/9\/761\/2075213\/blood_bld-2021-014766-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/9\/761\/2075213\/blood_bld-2021-014766-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T15:50:09Z","timestamp":1693497009000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/9\/761\/494149\/How-I-approach-bleeding-in-hospitalized-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014766","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}